Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study.
Schafer PH, Kivitz AJ, Ma J, Korish S, Sutherland D, Li L, Azaryan A, Kosek J, Adams M, Capone L, Hur EM, Hough DR, Ringheim GE. Schafer PH, et al. Among authors: kivitz aj. Rheumatol Ther. 2020 Mar;7(1):101-119. doi: 10.1007/s40744-019-00182-7. Epub 2019 Nov 13. Rheumatol Ther. 2020. PMID: 31721017 Free PMC article.
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 Study.
Pavelka K, Kivitz AJ, Dokoupilova E, Blanco R, Maradiaga M, Tahir H, Wang Y, Porter BO, Stefanska A, Richards HB, Rohrer S; MEASURE 3 study group. Pavelka K, et al. Among authors: kivitz aj. ACR Open Rheumatol. 2020 Feb;2(2):119-127. doi: 10.1002/acr2.11102. Epub 2020 Jan 20. ACR Open Rheumatol. 2020. PMID: 31957970 Free PMC article.
A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis.
Kivitz A, Kwong L, Shlotzhauer T, Lufkin J, Cinar A, Kelley S. Kivitz A, et al. Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19881309. doi: 10.1177/1759720X19881309. eCollection 2019. Ther Adv Musculoskelet Dis. 2019. PMID: 31662801 Free PMC article.
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
Kivitz AJ, Greenwald MW, Cohen SB, Polis AB, Najarian DK, Dixon ME, Moidel RA, Green JA, Baraf HS, Petruschke RA, Matsumoto AK, Geba GP; Protocol 085 Study Investigators. Kivitz AJ, et al. J Am Geriatr Soc. 2004 May;52(5):666-74. doi: 10.1111/j.1532-5415.2004.52201.x. J Am Geriatr Soc. 2004. PMID: 15086644 Clinical Trial.
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
van Holten J, Pavelka K, Vencovsky J, Stahl H, Rozman B, Genovese M, Kivitz AJ, Alvaro J, Nuki G, Furst DE, Herrero-Beaumont G, McInnes IB, Musikic P, Tak PP. van Holten J, et al. Among authors: kivitz aj. Ann Rheum Dis. 2005 Jan;64(1):64-9. doi: 10.1136/ard.2003.020347. Epub 2004 Jul 8. Ann Rheum Dis. 2005. PMID: 15242865 Free PMC article. Clinical Trial.
163 results